Cryo-Cell International (CCEL) vs Sotera Health (SHC)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 10, 2026.
Summary
Sotera Health (SHC) has outperformed Cryo-Cell International (CCEL) over the past year, gaining 14.4% versus a loss of 6.9%. Over five years, SHC leads with a -30.9% price change compared with -68.3% for CCEL. Sotera Health is the larger company by market cap ($5.15 billion vs $35.2 million), about 146.6 times the size.
On valuation, Sotera Health trades at a lower forward P/E (16.8x vs 218.0x for Cryo-Cell International).
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | CCEL | SHC |
|---|---|---|
| Share price | $4.36 | $18.06 |
| Market cap | $35.15M | $5.15B |
| 1-day change | +4.56% | +1.29% |
| YTD return | +21.22% | +2.38% |
| 1-year return | -6.92% | +14.45% |
| 5-year return | -68.29% | -30.94% |
| P/E ratio (TTM) | — | 31.68 |
| Forward P/E | 218.00 | 16.78 |
| EPS (TTM) | $-0.23 | $0.57 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | — | $1.16B |
| Revenue growth (YoY) | — | +5.74% |
| Net income (latest FY) | — | $77.95M |
| Gross margin | — | 55.48% |
| Net margin | — | 6.70% |
| 52-week high | $4.90 | $19.85 |
| 52-week low | $2.72 | $13.09 |
| Distance from 52-week high | -11.02% | -9.02% |
| Analyst consensus | — | buy |
| Avg. price target upside | — | +25.80% |
| Average volume | 24.34K | 2.50M |
| Shares outstanding | 8.06M | 285.37M |
| Employees | 72 | 3,000 |
| Sector | Health Care | Health Care |
| Industry | Misc Health and Biotechnology Services | Misc Health and Biotechnology Services |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Sotera Health is about 146.6 times larger than Cryo-Cell International by market value ($5.15B vs $35.15M).
- SHC has outperformed CCEL by 21.4 percentage points over the past year.
About Cryo-Cell International
CCEL stock →Cryo-Cell International, Inc. engages in cord blood and cord tissue cryopreservation services in the United States.
Health Care · Misc Health and Biotechnology Services · 72 employees
About Sotera Health
SHC stock →Sotera Health Company provides sterilization solutions, lab testing, and advisory services for the healthcare industry in the United States, Canada, Europe, and internationally. The company operates through three segments: Sterigenics, Nordion, and Nelson Labs.
Health Care · Misc Health and Biotechnology Services · 3,000 employees
CCEL vs SHC FAQ
Which is bigger, Cryo-Cell International or Sotera Health?
Sotera Health (SHC) is larger, with a market capitalization of $5.15B compared with $35.15M for Cryo-Cell International (CCEL).
Which stock has performed better over the past year, CCEL or SHC?
SHC returned +14.45% over the past 12 months, compared with -6.92% for CCEL (price return, excluding dividends). Past performance does not predict future results.
Are Cryo-Cell International and Sotera Health in the same industry?
Yes. Both are classified in the Misc Health and Biotechnology Services industry within the Health Care sector.